HYPERION DEFI, INC. Severance Costs
HYPERION DEFI, INC. (HYPD) reported Severance Costs of $332.75 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2022-03-30
- HYPERION DEFI, INC. severance costs for the quarter ending 2019-12-31 was $0.00.
- HYPERION DEFI, INC. severance costs for the quarter ending 2019-09-30 was $0.00.
- HYPERION DEFI, INC. severance costs for the quarter ending 2019-06-30 was $0.00.
- HYPERION DEFI, INC. severance costs for the quarter ending 2019-03-31 was $419.00K.
- HYPERION DEFI, INC. severance costs for fiscal 2021 was $332.75K, a 20.58% decline from fiscal 2020.
- HYPERION DEFI, INC. severance costs for fiscal 2020 was $419.00K, a 0.00% change from fiscal 2019.
- HYPERION DEFI, INC. severance costs for fiscal 2019 was $419.00K, a 0.00% change from fiscal 2018.
- HYPERION DEFI, INC. severance costs for fiscal 2018 was $419.00K.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $332.75K 10-K · filed 2022-03-30 | |||
| 2020-12-31 | $419.00K 10-K · filed 2021-03-30 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | $0.00 derived: sum of 3 quarters · filed 2020-03-30 | $419.00K 10-K · filed 2020-03-30 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $419.00K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $419.00K 10-Q · filed 2019-08-13 | ||
| 2019-03-31 | $419.00K 10-Q · filed 2019-05-14 | |||
| 2018-12-31 | $419.00K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |